Later on, the expression of NCAPG was often closely associated with the survival outcome and clinical pathology of patients with diseases such as NSCLC, renal clear cell carcinoma, breast cancer, and gastric cancer [27]. This evidence concerns the gene NCAPG and clear cell renal carcinoma.